- Home
- COEP vs TKNO Comparison
COEP vs TKNO Comparison
Compare COEP & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | TKNO |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 107.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COEP | TKNO |
|---|---|---|
| Price | $11.86 | $2.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 59.3K | ★ 371.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.26 | $1.91 |
| 52 Week High | $21.41 | $8.65 |
Technical Indicators
Market Signals| Indicator | COEP | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 16.20 |
| Support Level | $11.38 | $1.96 |
| Resistance Level | $12.40 | $2.26 |
| Average True Range (ATR) | 1.19 | 0.28 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 23.85 | 6.59 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.